文献速递血栓与止血

含237个氨基酸B结构域的凝血因子VIII在F8基因敲除小鼠中具有延长的半衰期

Factor VIII with a 237 amino acid B-domain has an extended half-life in F8-knockout mice.
PubMed 文献 · J Thromb Haemost · 2019-01-25

本研究在体外和F8基因敲除小鼠中比较了不同B结构域长度(186–240个氨基酸)的凝血因子VIII(FVIII)。含237个氨基酸B结构域的FVIII(FVIII-237)较含21个氨基酸B结构域的FVIII(FVIII-21)在F8基因敲除小鼠中半衰期延长1.6倍,且体外和体内活性及与血管性血友病因子结合相当。FVIII-237与表达LDL受体相关蛋白1(LRP-1)的细胞结合明显减少,可能解释其半衰期延长。

要点

  • B结构域长度在186–240个氨基酸之间的FVIII变体在F8基因敲除小鼠中半衰期长于更短或更长的变体。
  • FVIII-237较FVIII-21在F8基因敲除小鼠中半衰期延长1.6倍,体外和体内活性及与血管性血友病因子结合相当。
  • FVIII-237与表达LRP-1的细胞结合明显减少,可能与半衰期延长有关。

核心结论

  • FVIII-237细胞结合减少可能解释其在F8基因敲除小鼠中观察到的半衰期延长。
  • 这可能有助于解释使用类似B结构域长度的FVIII构建体进行的小鼠基因治疗研究中测得的FVIII水平升高。

研究设计与样本

  • 在体外和F8基因敲除小鼠中表征含中间长度B结构域的FVIII。
  • 比较B结构域为186–240个氨基酸的FVIII分子与更短或更长B结构域FVIII分子在F8基因敲除小鼠中的半衰期。

主要发现

  • B结构域为186–240个氨基酸的FVIII分子在F8基因敲除小鼠中半衰期长于更短或更长B结构域的FVIII分子。
  • FVIII-237在F8基因敲除小鼠中半衰期较FVIII-21延长1.6倍。
  • FVIII-237的体外和体内活性与FVIII-21相当,与血管性血友病因子结合也相当。
  • FVIII-237与表达LRP-1的细胞结合较FVIII-21明显减少,而表面等离子共振(SPR)研究中与LRP-1的亲和力未降低。
  • 由FVIII B结构域226个N端氨基酸组成的片段可抑制FVIII-21的细胞结合和内化,SPR分析提示该B结构域片段可能与FVIII-21以弱亲和力结合。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Essentials Factor (F)VIII with an intermediate-length B-domain showed higher levels in murine gene therapy. FVIII with different B-domain lengths were analysed. FVIII variants with B-domains between 186 and 240 amino acids (aa) have extended half-life in mice. Reduced cell binding of FVIII with a 237aa B-domain may explain the extended half-life. SUMMARY: Background Factor VIII consists of the A1-domain, A2-domain, B-domain, A3-domain, C1-domain, and C2-domain. FVIII with an intermediate-length B-domain of 226 amino acids (aa) has previously been evaluated in murine gene therapy studies. Objective To characterize FVIII with intermediate-length B-domains in vitro and in vivo in F8-knockout (KO) mice. Methods and results FVIII molecules with B-domains of 186-240aa had longer half-lives in F8-KO mice than FVIII molecules with shorter or longer B-domains. FVIII with a B-domain containing the 225 N-terminal aa fused to the 12 C-terminal aa of the wild-type B-domain (FVIII-237) had a 1.6-fold extended half-life in F8-KO mice as compared with FVIII with a 21aa B-domain (FVIII-21). The in vitro and in vivo activity of FVIII-237 were comparable to those of FVIII-21, as was binding to von Willebrand factor. Cell binding to LDL receptor-related protein 1 (LRP-1)-expressing cells was markedly reduced for FVIII-237 as compared with FVIII-21, whereas the affinity for LRP-1 was not reduced in surface plasmon resonance (SPR) studies. FVIII-21 cell binding and internalization could be inhibited by a fragment consisting of the 226 N-terminal aa of the FVIII B-domain, and SPR analysis suggested that this B-domain fragment might bind with weak affinity to FVIII-21. Conclusion Reduced cell binding of FVIII-237 might explain the observed extended half-life in F8-KO mice. This may contribute to the increased FVIII levels measured in murine gene therapy studies using FVIII constructs with similar B-domain lengths.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Bloem E, Karpf DM, Nørby PL, et al. Factor VIII with a 237 amino acid B-domain has an extended half-life in F8-knockout mice. J Thromb Haemost. 2019. PMID: 30525289. doi:10.1111/jth.14355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。